Solution structure of nociceptin peptides

Journal of Peptide Science

Volumn 8, Issue 9, 2002, Pages 497-509

  Amodeo, Pietro ^a   Guerrini, Remo ^b   Picone, Delia ^c   Salvadori, Severo ^b   Spadaccini, Roberta ^c   Tancredi, Teodorico ^a   Temussi, Piero A ^a,c  

^a CNR   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Allodynia; Analgesics; NMR; Nociceptin; Opioids

Indexed keywords

ANALGESIC AGENT; ANOREXIGENIC AGENT; APPETITE STIMULANT; DYNORPHIN; LIGAND; MEMBRANE PROTEIN; NALOXONE; NOCICEPTIN; NOCICEPTIN DERIVATIVE; NOCICEPTIN RECEPTOR AGONIST; NOCICEPTIN RECEPTOR ANTAGONIST; NOCISTATIN; OPIATE ANTAGONIST; OPIATE DERIVATIVE; OPIATE RECEPTOR; PEPTIDE DERIVATIVE; PEPTIDE HORMONE;

AMINO ACID SEQUENCE; ANALGESIC ACTIVITY; ANTICONVULSANT ACTIVITY; BIOMIMETICS; COMPLEX FORMATION; CONTROLLED STUDY; DRUG CONFORMATION; DRUG DEPENDENCE TREATMENT; DRUG RECEPTOR BINDING; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; STRUCTURE ACTIVITY RELATION; TRANQUILIZING ACTIVITY;

ANIMALS; BINDING SITES; CELL MEMBRANE; EXTRACELLULAR SPACE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; OPIOID PEPTIDES; RECEPTORS, CELL SURFACE; SOLUTIONS;

EID: 0036738876     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.412     Document Type: Review

References (62)

1. Meunier J-C, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butour J-L, Guillemot J-C, Ferrara P, Monsarrat B, Mazargull H, Vassart G, Parmentier M, Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 1995; 377: 532-535.
2. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningse RA, Bunzow JR, Grandy DK, Langen H, Monsma F Jr, Civelli O. Orphanin FQ: a neuropeptide that activates an opioid like G protein-coupled receptor. Science 1995; 270: 792-794.
3. Xue Ji-C, Chen C, Zhu J, Kunapuli S, DeRiel JK, Yu L, Liu-Chen Lee-Y. Differential binding domains of peptide and non-peptide ligands in the cloned rat kappa opioid receptor. J. Biol. Chem. 1994; 269: 30 195-30 199.
4. Reinscheid RK, Ardati A, Monsma FJ, Civelli O. Structure-activity relationship studies on the novel neuropeptide orphanin FQ. J Biol. Chem. 1996; 271: 14 163-14 168.
5. Schwyzer R. Estimated conformation, orientation, and accumulation of dynorphin A-(1-13)-tridecapeptide on the surface of neutral lipid membranes. Biochemistry 1986; 25: 6335-6342.
6. Calo' G, Rizzi M, Neugebauer W, Salvadori S, Guerrini R, Bianchi C, Regoli D. Pharmacological characterization of nociceptin receptor: an in vitro study. Can. J. Pharmacol. 1997; 75: 713-718.
7. Calo' G, Guerrini R, Rizzi A, Salvadori S, Regoli D. Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br. J. Pharmacol. 2000; 129: 1261-1283.
8. Mogil JS, Grisel JE, Zhangs G, Belknap JK, Grandy DK. Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ. Neurosci. Lett. 1996; 214: 131-134.
9. Mollerau C, Simons MJ, Soularue P, Liners F, Vassart G, Meunier JC, Parmentier M. Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc. Natl Acad. Sci. USA 1996; 93: 8666-8670.
10. Nothacker HP, Reinscheid RK, Mansour A, Henningsen RA, Ardati A, Monsma FJ Jr, Watson SJ, Civelli O. Primary structure and tissue distribution of the orphanin FQ precursor. Proc. Natl Acad. Sci. USA 1996; 93: 8677-8682.
11. Okuda-Ashitaka E, Toshiaki M, Tachibana S, Yoshihara Y, Nishiuchi Y, Kimura T, Ito S. Nocistatin, a peptide that blocks nociceptin action in pain transmission. Nature 1998; 392: 286-289.
12. Rossi GC, Mathis JP, Pasternak GW. Analgesic activity of orphanin FQ2, murine prepro-orphanin FQ 141-157 in mice. Neuroreport 1998; 9: 1165-1168.
13. Spadaccini R, Crescenzi O, Picone D, Tancredi T, Temussi PA. Solution structure of dynorphin A (1-17): a NMR study in a cryoprotective mixture at 278 K. J. Pept. Sci. 1998: 5: 306-312.
14. Salvadori S, Picone D, Tancredi T, Guerrini R, Spadaccini R, Lazarus LH, Regoli D, Temussi PA. Solution conformation of nociceptin. Biochem. Biophys. Res. Commun. 1997; 233: 640-643.
15. Crescenzi O, Guerrini R, Picone D, Salvadori S, Tancredi T, Temussi PA. Solution structure of nocistatin, a new peptide analgesic. Biopolymers 2000; 53: 257-264.
16. Temussi PA, Picone D, Castiglione-Morelli MA, Motta A, Tancredi T. Bioactive conformation of linear peptides in solution. An elusive goal? Biopolymers 1989; 28: 91-107.
17. Niccolai N, Garsky V, Gibbons WA. Proton spin-lattice relaxation studies of (D-Ala2-Met5) enkephalin. J. Am. Chem. Soc. 1980; 102: 1517-1520.
18. Bothner-By AA, Stephens RL, Lee J, Warren CD, Jeanloz RW. Structure determination of a tetrasaccharide: transient nuclear Overhauser effects in the rotating frame. J. Am. Chem. Soc. 1984: 106: 811-813.
19. Motta A, Tancredi T, Temussi PA. NOE in linear peptides. A low temperature 500 MHz study of metenkephalin. FEBS Lett. 1987; 215: 215-218.
20. Motta A, Picone D, Tancredi T, Temussi PA. NOE measurements on linear peptides in cryoprotective solvents. J. Magn. Reson. 1987; 75: 364-370.
21. Santoro M, Liu Y, Khan SMA, Hou L-X, Bolen DW. Increased thermal stability of proteins in the presence of naturally occurring osmolytes. Biochemistry 1992; 31: 5278-5283.
22. Matthews SJ, Leatherbarrow RJ. The use of osmolytes to facilitate protein NMR spectroscopy. J. Biomol. NMR 1993; 3: 597-600.
23. Douzou P, Petsko GA. Proteins at work: 'stop-action' pictures at subzero temperatures. Adv. Protein Chem. 1984; 36: 245-361.
24. Amodeo P, Motta A, Picone D, Saviano G, Tancredi T, Temussi PA. Viscosity as a conformational sieve. NOE of linear peptides in cryoprotective mixtures. J Magn. Reson. 1991; 95: 201-207.
25. Chapman D, Peel WT. In The Aqueous Cytoplasm, Keith AD (ed.). Dekker: New York, 1976; 137-178.
26. Fiori S, Renner C, Cramer J, Pegoraro S, Moroder L. Preferred conformation of endomorphin-1 in aqueous and membrane-mimetic environments. J. Mol. Biol. 1999; 291: 163-175.
27. Yan C, Digate RJ, Guiles RD. NMR studies of the structure and dynamics of peptide E, an endogenous opioid peptide that binds with high affinity to multiple opioid receptor subtypes. Biopolymers 1999; 49: 55-70.
28. 1H NMR. Eur. J. Biochem. 1990; 192: 433-439.
29. 1H-NMR spectroscopy. Biopolymers 1990; 30: 899-909.
30. Rinaldi F, Lin M, Shapiro MJ, Petersheim M. Delta-opiate DPDPE in magnetically oriented phospholipid micelles: binding and arrangement of aromatic pharmacophores. Biophys. J. 1997; 73: 3337-3348.
31. Tessmer MR, Meyer JP, Hruby VJ, Kallick DA. Structural model of a cyclic dynorphin A analog bound to dodecylphosphocholine micelles by NMR and restrained molecular dynamics. J. Med. Chem. 1997; 40: 2148-2155.
32. Tessmer MR, Kallick DA. NMR and structural model of dynorphin A (1-17) bound to dodecylphosphocholine micelles. Biochemistry 1997; 36: 1971-1981.
33. Carpenter KA, Wilkes BC, Weltrowska G, Schiller PW. Role of hydrophobic substituents in the interaction of opioid Tyr-Tic dipeptide analogs with dodecylphosphocholine micelles. Molecular partitioning in model membrane systems. Eur. J. Biochem. 1996: 241: 756-764.
34. Kallick DA. Conformation of dynorphin A (1-17) bound to dodecylphosphocholine micelles. J. Am. Chem. Soc. 1997; 115: 9317-9318.
35. Segawa M, Ohno Y, Doi M, Ishida T, Iwashita T. Solution conformation of mu-selective dermorphin and delta-selective deltorphin-I in phospholipid micelles, studied by NMR spectroscopy and molecular dynamics simulations. Int. J. Pept. Protein Res. 1995; 46: 37-46.
36. Deber CM, Behnam BA. Role of membrane lipids in peptide hormone function: binding of enkephalins to micelles. Proc. Natl Acad. Sci. USA 1984; 81: 61-65.
37. Schwyzer R. 100 years of lock-and-key concept: are peptide keys shaped and guided to their receptors by the target cell membrane? Biopolymers 1995; 37: 5-16.
38. Pogozheva ID, Lomize AL, Mosberg HI. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints. Biophys. J. 1998; 75: 612-634.
39. 1H-NMR study in methanol. Eur. J. Biochem. 1988; 173: 139-146.
40. Marion D, Zasloff M, Bax A. 1988. A two-dimensional NMR study of the antimicrobial peptide magainin 2. FEBS Lett. 1988; 227: 21-26.
41. Sonnichsen FD, Van Eyk JE, Hodges RS, Sykes BD. Effect of trifluoroethanol on protein secondary structure: an NMR and CD study using a synthetic actin peptide. Biochemistry 1992; 31: 8790-8798.
42. Verheyden P, De Wolf E, Jaspers H, Van Binst G. Comparing conformations at low temperature and at high viscosity. Conformational study of somatostatin and two of its analogues in methanol and in ethylene glycol. Int. J. Pept. Protein Res. 1994; 44: 401-409.
43. Reymond MT, Huo S, Duggan B, Wright PE, Dyson HJ. Contribution of increased length and intact capping sequences to the conformational preference for helix in a 31-residue peptide from the C-terminus of myohemerythrin. Biochemistry 1997; 36: 5234-5244.
44. Rajan R, Awasthi SK, Bhattachajya S, Balaram P. Teflon-coated peptides: hexafluoroacetone trihydrate as a structure stabilizer for peptides. Biopolymers 1997; 42: 125-128.
45. Saviano G, Crescenzi O, Picone D, Temussi PA, Tancredi T. Solution structure of human β-endorphin in helicogenic solvents: A NMR study. J. Pept. Sci. 1999; 5: 410-422.
46. Amodeo P, Lopez Mendez B, Guerrini R, Salvadori S, Temussi PA, Tancredi T. Pain peptides. Solution structure of orphanin FQ2. Biopolymers 2000; 53: 257-264.
47. Lancaster CRD, Mishra PK, Hughes DW, St-Pierre SA, Bothner-By AA, Epand RM. Mimicking the membrane-mediated conformation of dynorphin A (1-13) peptide: circular dichroism and nuclear magnetic resonance studies in methanolic solution. Biochemistry 1991; 30: 4715-4726.
48. Vaughn JB, Taylor JW. Proton NMR and CD solution conformation determination and opioid receptor binding studies of a dynorphin A (1-17) model peptide. Biochim. Biophys. Acta 1989; 999: 135-146.
49. 1H nuclear magnetic resonance study of the opioid peptide dynorphin-(1-13) in aqueous solution. J. Chem. Soc. Perkin Trans. II 1986; 637-644.
50. 15N-Leu-enkephalin. J. Pept. Sci. 1998; 4: 253-265.
51. Deschamps JR, George C, Flippen-Anderson JL. Structural studies of opioid peptides: A review of recent progress in x-ray diffraction studies. Biopolymers 1996; 40: 121-139.
52. Salvadori S, Guerrini R, Calo' G, Regoli D. Structure-activity studies on nociceptin/orphanin FQ: from full agonist to partial agonist, to pure antagonist. II Farmaco 1999; 54: 810-825.
53. Guerrini R, Calo' G, Rizzi A, Bigoni R, Rizzi D, Regoli D, Salvadori S. Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A. Peptides 2000; 7: 923-933.
54. Guerrini R, Rizzi A, Bianchi C, Lazarus LH, Salvadori S, Temussi PA, Regoli D. Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide. J. Med. Chem. 1997; 40: 1789-1793.
55. Lapalu S, Moisand C, Mazarguil H, Cambois G, Mollereau C, Meunier JC. Comparison of the structure-activity relationships of nociceptin and dynorphin A using chimeric peptides. FEBS Lett. 1997; 417: 333-336.
56. Venkatachalam CM. Stereochemical criteria for polypeptides and proteins. V. Conformation of a system of three linked peptide units. Biopolymers 1968; 6: 1425-1436.
57. Chou PY, Fasman GD. Beta-turns in proteins. J. Mol. Biol. 1977; 115: 135-175.
58. Wilmot CM, Thornton JM. Analysis and prediction of the different types of beta-turn in proteins. J. Mol. Biol. 1988; 203: 221-232.
59. Weiner SJ, Kollman PA, Nguyen DT, Case DA. An all-atom force-field for simulations of proteins and nucleic acids. J. Comput. Chem. 1986; 7: 230-252.
60. Pearlman DA, Case DA, Caldwell JW, Ross WS, Cheatham III TE, DeBolt S, Ferguson D, Seibel G, Kollman PA. AMBER, a computer program for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to elucidate the structures and energies of molecules. Comput. Phys. Commun. 1995; 91: 1-41.
61. Guentert P, Mumenthaler C, Wuethrich K. Torsion angle dynamics for NMR structure calculation with the new program DYANA. J. Mol. Biol. 1997; 273: 283-298.
62. Koradi R, Billeter M, Wuethrich K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 1996; 14: 51-55.